Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06CAS
|
|||
| Drug Name |
Cerliponase Alfa
|
|||
| Synonyms |
Brineura
Click to Show/Hide
|
|||
| Drug Type |
Recombinant protein
|
|||
| Indication | Neuronal ceroid lipofuscinosis [ICD-11: 5C56.1; ICD-10: E75.4] | Approved | [1] | |
| Tripeptidyl peptidase 1 deficiency [ICD-11: 5C50] | Approved | [2] | ||
| Company |
BioMarin Pharmaceutical
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Tripeptidyl-peptidase I (TPP1) | Target Info | Modulator | [3] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2018 | |||
| REF 2 | 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85. | |||
| REF 3 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.